These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 38560348)
1. Tumor-treating fields dosimetry in glioblastoma: Insights into treatment planning, optimization, and dose-response relationships. Mikic N; Gentilal N; Cao F; Lok E; Wong ET; Ballo M; Glas M; Miranda PC; Thielscher A; Korshoej AR Neurooncol Adv; 2024; 6(1):vdae032. PubMed ID: 38560348 [TBL] [Abstract][Full Text] [Related]
2. Correlation of Tumor Treating Fields Dosimetry to Survival Outcomes in Newly Diagnosed Glioblastoma: A Large-Scale Numerical Simulation-Based Analysis of Data from the Phase 3 EF-14 Randomized Trial. Ballo MT; Urman N; Lavy-Shahaf G; Grewal J; Bomzon Z; Toms S Int J Radiat Oncol Biol Phys; 2019 Aug; 104(5):1106-1113. PubMed ID: 31026557 [TBL] [Abstract][Full Text] [Related]
3. Guidelines for Burr Hole Surgery in Combination With Tumor Treating Fields for Glioblastoma: A Computational Study on Dose Optimization and Array Layout Planning. Cao F; Mikic N; Wong ET; Thielscher A; Korshoej AR Front Hum Neurosci; 2022; 16():909652. PubMed ID: 35782043 [TBL] [Abstract][Full Text] [Related]
4. Combined radiotherapy and concurrent tumor treating fields (TTFields) for glioblastoma: Dosimetric consequences on non-coplanar IMRT as initial results from a phase I trial. Guberina N; Pöttgen C; Kebir S; Lazaridis L; Scharmberg C; Lübcke W; Niessen M; Guberina M; Scheffler B; Jendrossek V; Jabbarli R; Pierscianek D; Sure U; Schmidt T; Oster C; Hau P; Grosu AL; Stuschke M; Glas M; Nour Y; Lüdemann L Radiat Oncol; 2020 Apr; 15(1):83. PubMed ID: 32307022 [TBL] [Abstract][Full Text] [Related]
5. Technical note: Computational study on thermal management schemes for tumor-treating fields therapy. Yang X; Hu C; Li L Med Phys; 2024 Oct; 51(10):7632-7644. PubMed ID: 39023183 [TBL] [Abstract][Full Text] [Related]
6. Impact of tumor position, conductivity distribution and tissue homogeneity on the distribution of tumor treating fields in a human brain: A computer modeling study. Korshoej AR; Hansen FL; Thielscher A; von Oettingen GB; Sørensen JCH PLoS One; 2017; 12(6):e0179214. PubMed ID: 28604803 [TBL] [Abstract][Full Text] [Related]
7. Planning TTFields treatment using the NovoTAL system-clinical case series beyond the use of MRI contrast enhancement. Connelly J; Hormigo A; Mohilie N; Hu J; Chaudhry A; Blondin N BMC Cancer; 2016 Nov; 16(1):842. PubMed ID: 27809808 [TBL] [Abstract][Full Text] [Related]
8. Prevention and Management of Dermatologic Adverse Events Associated With Tumor Treating Fields in Patients With Glioblastoma. Lacouture ME; Anadkat MJ; Ballo MT; Iwamoto F; Jeyapalan SA; La Rocca RV; Schwartz M; Serventi JN; Glas M Front Oncol; 2020; 10():1045. PubMed ID: 32850308 [No Abstract] [Full Text] [Related]
9. The Impact of Tumor Treating Fields on Glioblastoma Progression Patterns. Glas M; Ballo MT; Bomzon Z; Urman N; Levi S; Lavy-Shahaf G; Jeyapalan S; Sio TT; DeRose PM; Misch M; Taillibert S; Ram Z; Hottinger AF; Easaw J; Kim CY; Mohan S; Stupp R Int J Radiat Oncol Biol Phys; 2022 Apr; 112(5):1269-1278. PubMed ID: 34963556 [TBL] [Abstract][Full Text] [Related]
10. A Review on Tumor-Treating Fields (TTFields): Clinical Implications Inferred From Computational Modeling. Wenger C; Miranda PC; Salvador R; Thielscher A; Bomzon Z; Giladi M; Mrugala MM; Korshoej AR IEEE Rev Biomed Eng; 2018; 11():195-207. PubMed ID: 29993870 [TBL] [Abstract][Full Text] [Related]
11. Personalized optimization strategy for electrode array layout in TTFields of glioblastoma. Wang L; Chen C; Xiao Y; Gong R; Shen J; Lu M Int J Numer Method Biomed Eng; 2024 Oct; 40(10):e3859. PubMed ID: 39154656 [TBL] [Abstract][Full Text] [Related]
12. Optimization of tumor treating fields using singular value decomposition and minimization of field anisotropy. Korshoej AR; Sørensen JCH; von Oettingen G; Poulsen FR; Thielscher A Phys Med Biol; 2019 Feb; 64(4):04NT03. PubMed ID: 30641498 [TBL] [Abstract][Full Text] [Related]
13. The Clinical Application of Tumor Treating Fields Therapy in Glioblastoma. Riley MM; San P; Lok E; Swanson KD; Wong ET J Vis Exp; 2019 Apr; (146):. PubMed ID: 31058901 [TBL] [Abstract][Full Text] [Related]
14. Tumor treating fields: a comprehensive overview of the underlying molecular mechanism. Hong P; Kudulaiti N; Wu S; Nie J; Zhuang D Expert Rev Mol Diagn; 2022 Jan; 22(1):19-28. PubMed ID: 34883030 [TBL] [Abstract][Full Text] [Related]
15. Integration of Tumor-Treating Fields into the Multidisciplinary Management of Patients with Solid Malignancies. Wang Y; Pandey M; Ballo MT Oncologist; 2019 Dec; 24(12):e1426-e1436. PubMed ID: 31444292 [TBL] [Abstract][Full Text] [Related]
16. First Report of Tumor Treating Fields (TTFields) Therapy for Glioblastoma in Comorbidity with Multiple Sclerosis. Kassubek R; Mathieu R Brain Sci; 2022 Apr; 12(4):. PubMed ID: 35448029 [TBL] [Abstract][Full Text] [Related]
17. Importance of electrode position for the distribution of tumor treating fields (TTFields) in a human brain. Identification of effective layouts through systematic analysis of array positions for multiple tumor locations. Korshoej AR; Hansen FL; Mikic N; von Oettingen G; Sørensen JCH; Thielscher A PLoS One; 2018; 13(8):e0201957. PubMed ID: 30133493 [TBL] [Abstract][Full Text] [Related]